Skip to main content
An official website of the United States government

Supportive Care and Symptom Management

The Supportive Care and Symptom Management program supports studies on the prevention or treatment of acute and chronic symptoms and morbidities related to cancer and its treatment. This includes the impact on the quality of life of patients and their informal caregivers. The program also supports studies of patients and their caregivers at the end of life.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Supportive Care and Symptom Management

The program supports research in three areas: prevention or treatment of acute or chronic symptoms and morbidities related to cancer, its treatment and caregiving (symptom management research); effects on quality of life from cancer, its treatment and caregiving (quality of life research); and end-of-life psychosocial issues, caregiving and treatment strategies (end-of-life research).

Through the NCI Community Oncology Research Program (NCORP), clinical trials are underway to evaluate therapies to prevent or ameliorate a broad range of symptoms and/or toxicities associated with cancer its treatment and caregiving. Other studies funded separately are investigating a range of treatment effects on health-related quality of life and a variety of influences on the end-of-life cancer experience. 

Topic Areas include: Anorexia, Cachexia, Cardiotoxicity, Caregiver Issues, Cognitive Dysfunction, Distress/Anxiety/Depression, End of Life, Fatigue, Geriatrics, Hot Flashes, Lymphedema, Medication Adherence, Mucositis, Multiple Symptoms, Musculoskeletal Symptoms, Nausea, Neuropathy, Nutrition, Oral Complications, Other Supportive Care Issues, Pain, Palliative Care, Pediatrics/Adolescents/Young Adult, Physical Functioning, Quality of Life, Skin Toxicities, Sleep Disorders, and Urinary Complications.

Selected Topics

Funding Opportunities

Title Sort ascending Announcement Number Activity Code Clinical Trials Status Expiration Date Program Official
HEAL Initiative: Studies to Enable Analgesic Discovery RFA-NS-25-023 (R61/R33 - Clinical Trial Not Allowed) R61, R33 Clinical Trial Not Allowed 02/20/2027 Rachel Altshuler, Ph.D.

Grantee Details

PI Name PI Organization Title Grant Number Program Official
Shu, Xiao-Ou

Vanderbilt University Medical Center
United States

Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer 5R01CA227133-05 Matthew Young, Ph.D.
Germain, Doris A

Icahn School Of Medicine At Mount Sinai
United States

Exploring ovarian-derived hormone STC1 as the mediator of the protective effect of breast feeding against breast cancer. 5R21CA270702-02 Marjorie Perloff, M.D.
Flory, James H

Sloan-Kettering Inst Can Research
United States

Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life 5R21CA277464-02 Gabriela Riscuta, M.D., CNS
Flory, James H

Sloan-Kettering Inst Can Research
United States

Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life 5R21CA277464-02 Gabriela Riscuta, M.D., CNS
Pandharipande, Pari Vijay

Ohio State University
United States

Precision Management of Cystic Precursors to Pancreatic Cancer 5R01CA237133-06 Matthew Young, Ph.D.
Smith, Ellen Mary Lavoie

University Of Alabama At Birmingham
United States

Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study 5R01CA235726-07 Brennan Streck, Ph.D., RN, M.P.H.
Smith, Ellen Mary Lavoie

University Of Alabama At Birmingham
United States

Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study 5R01CA235726-07 Brennan Streck, Ph.D., RN, M.P.H.
Lee, Jeffrey Kuang Zou

Kaiser Foundation Research Institute
United States

Vanguard Study Administrative Supplement 3UG1CA287011-02S1 Elyse LeeVan, M.D., M.P.H.
Russell, John A

University Of Wisconsin-Madison
United States

Treatment of Functional Deficits IN tongue muscles induced by radiation and chemoradiation treatment 5R37CA225608-07 Cecilia Lee, Dr.P.H., RN
Russell, John A

University Of Wisconsin-Madison
United States

Treatment of Functional Deficits IN tongue muscles induced by radiation and chemoradiation treatment 5R37CA225608-07 Cecilia Lee, Dr.P.H., RN
Li, Bing

University Of Iowa
United States

E-FABP mediates n-3 fatty acid-induced tumor prevention through epigenetic control of immune cell differentiation and function 5R01CA180986-11 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Hayes, Richard Bernard

New York University School Of Medicine
United States

The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer 5R01CA159036-09 Claire Zhu, Ph.D.
Singal, Amit

Ut Southwestern Medical Center
United States

Precision Screening for Hepatocellular Carcinoma in Patients with Cirrhosis 5R01CA222900-06
Porter, Laura S

Duke University
United States

Couple Communication Skills Training for Advanced Cancer 5R01CA229425-05 Brennan Streck, Ph.D., RN, M.P.H.
Porter, Laura S

Duke University
United States

Couple Communication Skills Training for Advanced Cancer 5R01CA229425-05 Brennan Streck, Ph.D., RN, M.P.H.

Clinical Trials

Status
Title Sort ascending Intervention Sponsor Status
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia Best Practice, Biospecimen Collection, Cytarabine, Electronic Health Record Review, Placebo Administration, Xylitol-containing Oral Wipe Children's Oncology Group Not yet recruiting
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer Intensity-Modulated Radiation Therapy, Three-Dimensional Conformal Radiation Therapy NRG Oncology Active, not recruiting
Wellness App for Sleep Disturbance in Hematological Cancer Patients Wellness app intervention #1, Wellness app intervention #2 The University of Texas Health Science Center at San Antonio Recruiting
Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer Educational Intervention, Internet-Based Intervention, Laboratory Biomarker Analysis, Medical Device Usage and Evaluation, Quality-of-Life Assessment, Questionnaire Administration Children's Oncology Group Active, not recruiting
Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer Behavioral Intervention, Educational Intervention, Internet-Based Intervention, Interview, Survey Administration, Virtual Technology Intervention City of Hope Medical Center Not yet recruiting
Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer Best Practice, Informational Intervention, Informational Intervention with Coaching, Questionnaire Administration Alliance for Clinical Trials in Oncology Active, not recruiting
Understanding Needs of Older Patients Prior to Starting Cancer Treatment Assessment, Educational Intervention, Electronic Health Record Review, Internet-Based Intervention, Interview, Survey Administration Wake Forest University Health Sciences Enrolling by invitation
Understanding and Enhancing Health-Related Social Needs (HRSN) Screening Among Community Oncology Practices Non-Interventional Wake Forest University Health Sciences Enrolling by invitation
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer Best Practice, Biospecimen Collection, Electronic Health Record Review, Survey Administration, Triptorelin Pamoate Children's Oncology Group Recruiting
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer Chemotherapy, Functional Assessment, Questionnaire Administration SWOG Cancer Research Network Active, not recruiting